⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IRON News
Disc Medicine, Inc. Common Stock
Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)
globenewswire.com
IRON
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
globenewswire.com
IRON